Literature DB >> 6271792

Ultrastructural localization of cyclic GMP and cyclic AMP in rat striatum.

M A Ariano, A I Matus.   

Abstract

The subcellular localization of cyclic GMP and cyclic AMP in the rat caudate-putamen has been studied using horseradish peroxidase immunocytochemistry. Both of the putative neurotransmitter second messengers were visualized in neurons and glial cells at light microscopic resolutions, but not all cells of either category gave detectable staining. This was confirmed at the ultrastructural level where both stained and unstained elements of the same cell type were found within the same field. A striking variation was seen in cyclic nucleotide staining intensity within individual neural and glial cells. Both of the cyclic nucleotides were detected within postsynaptic terminal boutons and within astroglial processes. Cyclic GMP postsynaptic staining was stronger than glial staining, whereas the localization pattern was reversed for cyclic AMP. The synaptic localization of cyclic AMP and cyclic GMP immunoreactivity adds support to the idea that these compounds have an influential role in synaptic function within the striatum.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6271792      PMCID: PMC2111920          DOI: 10.1083/jcb.91.1.287

Source DB:  PubMed          Journal:  J Cell Biol        ISSN: 0021-9525            Impact factor:   10.539


  21 in total

1.  Muscarinic cholinergic regulation of cyclic guanosine 3,5-monophosphate in autonomic ganglia: possible role in synaptic transmission.

Authors:  J W Kebabian; A L Steiner; P Greengard
Journal:  J Pharmacol Exp Ther       Date:  1975-05       Impact factor: 4.030

2.  Neurotransmitters increase cyclic nucleotides in postganglionic neurons: immunocytochemical demonstration.

Authors:  J W Kebabian; F E Blood; A L Steiner; P Greengard
Journal:  Science       Date:  1975-10-10       Impact factor: 47.728

3.  Regulation of levels of guanosine cyclic 3',5'-monophosphate in the central nervous system: effects of depolarizing agents.

Authors:  J A Ferrendelli; D A Kinscherf; M M Chang
Journal:  Mol Pharmacol       Date:  1973-07       Impact factor: 4.436

4.  Enhanced release of dopamine -hydroxylase and norepinephrine from sympathetic nerves by dibutyryl cyclic adenosine 3', 5'-monophosphate and theophylline.

Authors:  G F Wooten; N B Thoa; I J Kopin; J Axelrod
Journal:  Mol Pharmacol       Date:  1973-03       Impact factor: 4.436

5.  Effect of catecholamines on the adenosine 3':5'-cyclic monophosphate concentrations of clonal satellite cells of neurons.

Authors:  A G Gilman; M Nirenberg
Journal:  Proc Natl Acad Sci U S A       Date:  1971-09       Impact factor: 11.205

6.  A low-viscosity epoxy resin embedding medium for electron microscopy.

Authors:  A R Spurr
Journal:  J Ultrastruct Res       Date:  1969-01

7.  Role of muscarinic cholinergic receptors in regulation of guanosine 3':5'-cyclic monophosphate content in mammalian brain, heart muscle, and intestinal smooth muscle.

Authors:  T P Lee; J F Kuo; P Greengard
Journal:  Proc Natl Acad Sci U S A       Date:  1972-11       Impact factor: 11.205

8.  Adenosine 3',5'-monophosphate in nervous tissue: increase associated with synaptic transmission.

Authors:  D A McAfee; M Schorderet; P Greengard
Journal:  Science       Date:  1971-03-19       Impact factor: 47.728

9.  Norepinephrine stinulated increase of cyclic AMP levels in developing mouse brain cell cultures.

Authors:  N W Seeds; A G Gilman
Journal:  Science       Date:  1971-10-15       Impact factor: 47.728

10.  Catecholamine-sensitive guanylate cyclase from human caudate nucleus.

Authors:  W H Frey; S E Senogles; L L Heston; V B Tuason; S E Nicol
Journal:  J Neurochem       Date:  1980-12       Impact factor: 5.372

View more
  11 in total

1.  Imaging cytoskeleton--mitochondrial membrane attachments by embedment-free electron microscopy of saponin-extracted cells.

Authors:  A Lin; G Krockmalnic; S Penman
Journal:  Proc Natl Acad Sci U S A       Date:  1990-11       Impact factor: 11.205

Review 2.  Role of nitric oxide on motor behavior.

Authors:  E A Del Bel; F S Guimarães; M Bermúdez-Echeverry; M Z Gomes; A Schiaveto-de-souza; F E Padovan-Neto; V Tumas; A P Barion-Cavalcanti; M Lazzarini; L P Nucci-da-Silva; D de Paula-Souza
Journal:  Cell Mol Neurobiol       Date:  2005-03       Impact factor: 5.046

Review 3.  A molecular description of nerve terminal function.

Authors:  L F Reichardt; R B Kelly
Journal:  Annu Rev Biochem       Date:  1983       Impact factor: 23.643

4.  Immunohistochemical localization of guanylate cyclase within neurons of rat brain.

Authors:  M A Ariano; J A Lewicki; H J Brandwein; F Murad
Journal:  Proc Natl Acad Sci U S A       Date:  1982-02       Impact factor: 11.205

Review 5.  Histochemistry of nucleotidyl cyclases and cyclic nucleotide phosphodiesterases.

Authors:  G Poeggel; H Luppa
Journal:  Histochem J       Date:  1988-05

6.  A new approach to the immunocytochemistry of cAMP. Initial characterization of antibodies against acrolein-fixed cAMP.

Authors:  J De Vente; J Schipper; H W Steinbusch
Journal:  Histochemistry       Date:  1993-06

7.  Reversible repression and activation of measles virus infection in neural cells.

Authors:  C A Miller; D R Carrigan
Journal:  Proc Natl Acad Sci U S A       Date:  1982-03       Impact factor: 11.205

8.  Regional changes of cyclic 3',5'-guanosine monophosphate in the spinal cord of the rabbit following brief repeated ischemic insults.

Authors:  J Pavel; N Lukácová; J Marsala
Journal:  Neurochem Res       Date:  2000-08       Impact factor: 3.996

9.  Modulation of methamphetamine-induced nitric oxide production by neuropeptide Y in the murine striatum.

Authors:  Haley L Yarosh; Jesus A Angulo
Journal:  Brain Res       Date:  2012-09-13       Impact factor: 3.252

10.  Frequency-Dependent Corticostriatal Disinhibition Resulting from Chronic Dopamine Depletion: Role of Local Striatal cGMP and GABA-AR Signaling.

Authors:  Vatsala R Jayasinghe; Eden Flores-Barrera; Anthony R West; Kuei Y Tseng
Journal:  Cereb Cortex       Date:  2017-01-01       Impact factor: 5.357

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.